‘Recognizing expected efficacy of drugs with same mechanism of action.’

It is definitely an unresolved conundrum. Experts have clashing opinions and each pharmaceutical company has different interests. In the end, what it comes down to is ‘case by case.’

Not that it needs an answer key, but obviously the prescribing doctor’s decision based on experience and medical knowledge is important. The problem is consistency in applying healthcare insurance reimbursement. For some classes, the effects are recognized regardless of the approved label and equivalent reimbursement criteria are applied, but some other classes have different scope of labels approved.

Reimbursement e